Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ortho Clinical Diagnostics Plc (OCDX)

Ortho Clinical Diagnostics Plc (OCDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,015,434
  • Shares Outstanding, K 222,585
  • Annual Sales, $ 2,043 M
  • Annual Income, $ -54,300 K
  • 60-Month Beta 1.32
  • Price/Sales 1.89
  • Price/Cash Flow 7.68
  • Price/Book 8.71
Trade OCDX with:

Options Overview Details

View History
  • Implied Volatility 1.21% ( -6.36%)
  • Historical Volatility 33.52%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 102.84% on 08/13/21
  • IV Low 1.21% on 05/18/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 2
  • Put/Call OI Ratio 0.57
  • Today's Open Interest 1,013
  • Open Int (30-Day) 1,003

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 0.16
  • Number of Estimates 3
  • High Estimate 0.20
  • Low Estimate 0.13
  • Prior Year 0.12
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.24 +8.62%
on 05/12/22
19.35 -8.82%
on 04/20/22
-0.86 (-4.65%)
since 04/18/22
3-Month
16.24 +8.62%
on 05/12/22
19.54 -9.72%
on 04/08/22
+0.56 (+3.28%)
since 02/18/22
52-Week
16.04 +9.98%
on 02/17/22
22.99 -23.27%
on 06/14/21
-2.20 (-11.09%)
since 05/18/21

Most Recent Stories

More News
Ortho Clinical Diagnostics Shareholders Approve Quidel Transaction

RARITAN, N.J., May 16, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) (“Ortho” or the “Company”), one of the world’s...

OCDX : 17.64 (-2.22%)
QDEL : 100.04 (-3.22%)
Ortho Clinical Diagnostics Holdings plc (OCDX) Q1 2022 Earnings Call Transcript

OCDX earnings call for the period ending March 31, 2022.

OCDX : 17.64 (-2.22%)
Ortho Clinical Diagnostics (OCDX) Q1 Earnings Top Estimates

Ortho Clinical (OCDX) delivered earnings and revenue surprises of 15% and 1.09%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

OCDX : 17.64 (-2.22%)
AGTI : 18.01 (-3.59%)
Why Ortho Clinical (OCDX) Could Beat Earnings Estimates Again

Ortho Clinical (OCDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

OCDX : 17.64 (-2.22%)
Ortho Clinical Diagnostics (OCDX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Ortho Clinical (OCDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

OCDX : 17.64 (-2.22%)
Ortho Clinical Diagnostics Recognized with Fifth Prestigious Edison Award for Highly Accurate COVID-19 Solution

Gold Award Recognizes Antibody Test...

OCDX : 17.64 (-2.22%)
Ortho Clinical Diagnostics to Report First Quarter 2022 Results on May 4, 2022

RARITAN, N.J., April 20, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world’s largest pure-play in vitro...

OCDX : 17.64 (-2.22%)
Ortho Clinical (OCDX) Upgraded to Strong Buy: Here's What You Should Know

Ortho Clinical (OCDX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

OCDX : 17.64 (-2.22%)
New Strong Buy Stocks for March 24th

ASRT, CPRI, GRIN, OCDX, and KN have been added to the Zacks Rank #1 (Strong Buy) List on March 24, 2022.

KN : 19.09 (-2.15%)
GRIN : 26.85 (+2.17%)
ASRT : 2.93 (-0.68%)
CPRI : 42.50 (-5.74%)
OCDX : 17.64 (-2.22%)
OCDX vs. PGNY: Which Stock Should Value Investors Buy Now?

OCDX vs. PGNY: Which Stock Is the Better Value Option?

OCDX : 17.64 (-2.22%)
PGNY : 35.18 (-6.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Ortho Clinical Diagnostics deals with in vitro and in vivo diagnostic substances.

See More

Key Turning Points

3rd Resistance Point 18.64
2nd Resistance Point 18.42
1st Resistance Point 18.03
Last Price 17.64
1st Support Level 17.42
2nd Support Level 17.20
3rd Support Level 16.81

See More

52-Week High 22.99
Fibonacci 61.8% 20.34
Fibonacci 50% 19.51
Fibonacci 38.2% 18.69
Last Price 17.64
52-Week Low 16.04

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar